What is Hyperfine Cash-to-Debt?
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Hyperfine's cash to debt ratio for the quarter that ended in Dec. 2023 was 406.40.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Hyperfine could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.
The historical rank and industry rank for Hyperfine's Cash-to-Debt or its related term are showing as below:
HYPR'
s Cash-to-Debt Range Over the Past 10 Years
Min: 352.11 Med: No Debt Max: No Debt
Current: 406.4
During the past 5 years, Hyperfine's highest Cash to Debt Ratio was No Debt. The lowest was 352.11. And the median was No Debt.
Hyperfine Cash-to-Debt Historical Data
The historical data trend for Hyperfine's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Hyperfine Cash-to-Debt Chart
|
Hyperfine Annual Data
|
|
Trend |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Cash-to-Debt |
|
No Debt |
352.11 |
No Debt |
No Debt |
406.40 |
|
Hyperfine Quarterly Data
|
|
Dec19 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Cash-to-Debt |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
No Debt |
No Debt |
No Debt |
No Debt |
406.40 |
Competitive Comparison of Hyperfine's Cash-to-Debt
For the Medical Devices subindustry, Hyperfine's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hyperfine's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hyperfine's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Hyperfine's Cash-to-Debt falls into.
Hyperfine Cash-to-Debt Calculation
This is the ratio of a company's
Cash, Cash Equivalents, Marketable Securities
to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.
Hyperfine's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:
Hyperfine's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hyperfine (Hyperfine) Business Description
Traded in Other Exchanges
N/A
Address
351 New Whitfield Street, Guilford, CT, USA, 06437
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. Legacy Hyperfine and Liminal represent two operating segments of the company. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
Executives
| Thomas Teisseyre |
officer: Chief Operating Officer |
C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437 |
| Khan Siddiqui |
officer: See Remarks |
530 OLD WHITFIELD STREET, GUILFORD CT 06437 |
| Brett Hale |
officer: Chief Administrative Officer |
C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437 |
| Maria Sainz |
director |
C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056 |
| Jonathan M Rothberg |
director, 10 percent owner |
C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437 |
| Alok Gupta |
officer: Chief Financial Officer |
530 OLD WHITFIELD STREET, GUILFORD CT 06437 |
| Neela Paykel |
officer: Gen Counsel & Corp Secretary |
530 OLD WHITFIELD STREET, GUILFORD CT 06437 |
| David D Scott |
director, officer: President and CEO |
530 OLD WHITFIELD STREET, GUILFORD CT 06437 |
| Ruth A Fattori |
director |
1303 EAST ALGONQUIN ROAD, SCHAUMBURG IL 60196 |
| Hc Sponsor Llc |
10 percent owner |
31 HUDSON YARDS, 10TH FLOOR, 28TH FLOOR, NEW YORK NY 10001 |
| Arthur Bruce Cohen |
10 percent owner |
12 SOUTH MAIN STREET, SUITE #203, NORWALK CT 06854 |
| Healthcor Group, Llc |
10 percent owner |
31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001 |
| Joseph Patrick Healey |
10 percent owner |
31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001 |
| R Scott Huennekens |
director |
C/O VOLCANO CORPORATION, 11455 EL CAMINO REAL, SUITE 460, SAN DIEGO CA 92130 |
| Scott A. White |
officer: Chief Commercial Officer |
530 OLD WHITFIELD STREET, GUILFORD CT 06437 |
Hyperfine (Hyperfine) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HYPR has been successfully added to your